Beard SM, Gaffney L, Bamber L. Economic modelling of antiplatelet therapy in the secondary prevention of stroke. Poster presented at the 2003 ISPOR 6th Annual European Congress; November 9, 2003. Barcelona, Spain.
von Scheele B, DePlatchett J, Gaffney L, Peña BM, Niculescu L. The total costs of treatment with valdecoxib compared to generic diclofenac are similar in patients with rheumatoid arthritis in Germany. Poster presented at the 2003 ISPOR 6th Annual European Congress; November 9, 2003. Barcelona, Spain. [abstract] Value Health. 2003 Nov; 6(6):725-6.
Sorensen SW, Hicks KA, Wirth K, Hoerger TJ, Narayan K, Saaddine J. Optimal allocation of resources based on the diabetes report card for quality care. Presented at the Institute for Operations Research and the Management Sciences Annual Meeting; October 2003.
Neighbors DM, McCory D, Pesa J. Cost-effectiveness and budget impact of zolmitriptan nasal spray. Poster presented at the 2003 AMCP Educational Conference; October 2003. Montreal, Canada.
Zarkin GA, Dunlap LJ, Hicks KA, Mamo D, Mobley LR. Benefits and costs of methadone treatment: results from a lifetime simulation model. Presented at the International Health Economics Association Meeting; June 15, 2003.
Fehnel SE, McLeod LD, Williams VS. Combining qualitative and quantitative techniques in the development of patient-reported outcome measures. Presented at the Eighth Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research; May 2003.
Hicks KA, Honeycutt A, Earnshaw SR, Richter A. Models for the efficient allocation of HIV prevention resources. Presented at the Community Planning Leadership Summit for HIV Prevention; March 2003.
Fehnel SE. Developing strategies for the measurement of patient-reported outcomes. Poster presented at the Fourth Annual Phase IV and Peri-Approval Clinical Research Conference conducted by Barnett International; February 1, 2003. Philadelphia, PA.
Beard S, Gaffney L, Bamber L. Economic modelling of antiplatelet therapy in the prevention of recurrent stroke. Value Health. 2003 Jan 1;6(6):650.